Disc Dynamics spinal nucleus replacement
This article was originally published in The Gray Sheet
Executive Summary
Firm announces Aug. 2 approval to commence a clinical study of its Dascor disc arthroplasty system. Dascor is a minimally invasive nucleus replacement device intended for patients with disc degeneration not yet severe enough to warrant total disc replacement. Data from the trial, scheduled to begin during the third quarter, will support a premarket approval application for the device. The firm received a CE mark for Dascor in July 2005. Disc Dynamics is vying with NuVasive (NeoDisc), Cryolife (BioDisc) and Raymedica (PDN-Solo) to market the first spinal nucleus replacement system in the U.S. (1"The Gray Sheet" Sept. 5, 2005, p. 5)...
You may also be interested in...
Financing In Brief
Disc Dynamics: Minnesota firm announces completion of $27 million financing round, with funds to go toward development of the minimally invasive Dascor disc arthroplasty system for treating lower back pain associated with degenerative disc disease. The nucleus replacement implant, CE-marked in Europe, is in a prospective, multicenter pilot clinical study in the United States. Privately owned Disc Dynamics was incorporated in 2000, with its first major financing round in 2004 (1"The Gray Sheet" Aug. 7, 2006, In Brief)...
FDA’s Ortho Panel To Consider Study Designs For Less Invasive Spinal Devices
Clinical trial design issues for non-fusion spinal stabilization implants are among topics likely to be discussed by FDA's Orthopedic and Rehabilitation Devices Panel Sept. 9 in Gaithersburg, Md
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.